Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

VIVO

Meridian Biosci

NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.15

+0.21

+1.11%

Opening 12:12 07/23 EDT

OPEN

18.96

PREV CLOSE

18.94

HIGH

19.27

LOW

18.71

VOLUME

239.50K

TURNOVER

52 WEEK HIGH

30.65

52 WEEK LOW

12.98

MARKET CAP

829.77M

P/E (TTM)

9.61

BRIEF-Meridian Signs Deal To Buy Urea Breath Test For H. Pylori From Otsuka America Pharmaceutical

reuters.com · 2h ago

Meridian Bioscience to acquire North American BreathTek business from Otsuka

Meridian Bioscience ([[VIVO]]) has signed a definitive agreement to acquire the North American BreathTek business from Otsuka America Pharmaceutical for $20M in cash.The transaction is expected to close in Meridian’s

Seekingalpha · 2h ago

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek...

GlobeNewswire · 2h ago

Meridian Bioscience to Acquire Otsuka's North American BreathTek Business for $20 Million

MT Newswires · 6h ago

Bullish Trend Continues In Cannabis Market: Tilray, Canopy Growth & GrowGen Among Top Cannabis Movers For July 21, 2021

GAINERS: Flower One Hldgs (OTC: FLOOF) shares closed up 17.57% at $0.15

Benzinga · 1d ago

Investors Shouldn't Overlook The Favourable Returns On Capital At Meridian Bioscience (NASDAQ:VIVO)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Simply Wall St. · 2d ago

Bearish Sentiment Toward Market: Cannabis Movers For July 19, 2021

GAINERS: Livewell Canada Inc (OTC: LMLLF) shares closed up 12.87% at $0.06

Benzinga · 3d ago

C21 Investments, 1933 Industries And Urban-Gro Among Top Cannabis Stock Movers On June 16, 2021

GAINERS: Heritage Cannabis Holding (OTC: HERTF) shares closed up 9.12% at $0.07ª

Benzinga · 6d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of VIVO. Analyze the recent business situations of Meridian Biosci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVO stock price target is 29.67 with a high estimate of 34.00 and a low estimate of 25.00.

EPS

Institutional Holdings

Institutions: 311

Institutional Holdings: 48.23M

% Owned: 111.30%

Shares Outstanding: 43.33M

TypeInstitutionsShares

Increased

2.72M

New

4.75M

Decreased

4.08M

Sold Out

1.03M

Performance
Asset Allocation
Dividend History

No Data

Industry

Medical Equipment, Supplies & Distribution

+0.83%

Healthcare Equipment & Supplies

+0.85%

Key Executives

Non-Executive Chairman/Independent Director

David Phillips

Chief Executive Officer/Director

John Kenny

Chief Financial Officer/Executive Vice President/Chief Accounting Officer/Secretary

Bryan Baldasare

Executive Vice President

Tony Serafini-Lamanna

Executive Vice President

Lourdes Weltzien

Independent Director

James Anderson

Independent Director

Anthony Bihl

Independent Director

Dwight Ellingwood

Independent Director

John McIlwraith

Independent Director

John Rice

Independent Director

Catherine Sazdanoff

Independent Director

Felicia Williams

Declaration Date Dividend Per Share Ex-Div Date: 01/22/2019
Dividend USD 0.125
02/01/2019; 11/07/2018
Dividend USD 0.125
11/16/2018; 07/24/2018
Dividend USD 0.125
08/09/2018; 04/25/2018
Dividend USD 0.125
05/04/2018; 01/24/2018
Dividend USD 0.125
02/02/2018; 11/08/2017
Dividend USD 0.125
11/17/2017; 07/25/2017
Dividend USD 0.125
08/03/2017; 04/25/2017
Dividend USD 0.125
05/04/2017; 01/25/2017
Dividend USD 0.125
02/02/2017; 11/09/2016
Dividend USD 0.2
11/17/2016; 07/26/2016
Dividend USD 0.2
08/04/2016; 04/26/2016
Dividend USD 0.2
05/05/2016; 01/26/2016
Dividend USD 0.2
02/04/2016; 11/04/2015
Dividend USD 0.2
11/12/2015; 07/21/2015
Dividend USD 0.2
07/30/2015; 04/21/2015
Dividend USD 0.2
04/30/2015; 01/21/2015
Dividend USD 0.2
01/29/2015; 11/05/2014
Dividend USD 0.2
11/13/2014; 07/22/2014
Dividend USD 0.2
07/31/2014; 04/22/2014
Dividend USD 0.2
05/01/2014

All
Financials
Insiders

About VIVO

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVO stock methods without spending real money on the virtual paper trading platform.